Executive Summary -
On October 19, 2023, the Food and Drug Administration (FDA) released a final guidance document titled Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry, providing...more
11/10/2023
/ Coronavirus/COVID-19 ,
Emergency Use Authorization (EUA) ,
Food and Drug Administration (FDA) ,
Licensing Rules ,
New Guidance ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
Vaccinations
This is the fourth part in our 2023 series examining important trends in white collar law and investigations. Up next: SEC.
Last year, as we laid out the landscape for congressional investigations in 2022, we noted that...more
2/23/2023
/ China ,
Competition ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Corporate Counsel ,
Environmental Social & Governance (ESG) ,
Government Entities ,
Inflation Reduction Act (IRA) ,
Infrastructure Investment and Jobs Act (IIJA) ,
Investigations ,
Private Sector ,
Technology Sector ,
Vaccinations ,
White Collar Crimes